Thoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine
Recruiting
N/A
Interventional Study
Postoperative Pain, Acute
Lung Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 210 (estimated)
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This randomized controlled trial evaluates the analgesic effects of liposomal bupivacaine compared to bupivacaine hydrochloride in intercostal nerve block for patients undergoing thoracoscopic lung surgery. Postoperative pain remains a significant issue in thoracic procedures, often leading to complications like pneumonia or delayed recovery. The investigators hypothesize that liposomal bupivacain…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Scheduled for elective unilateral thoracoscopic (VATS) lung surgery
* Age 18 to 80 years
* American Society of Anesthesiologists (ASA) physical status I-III
Exclusion Criteria:
* Contraindication to local anesthetics (infection at puncture site, allergy to local anesthetics,…
Contacts